Hitachi and The Guardian Host Debate on Technology, Social Innovation and the Future of Healthcare

Hitachi 26 November 2014, London, UK.
Hitachi Europe Ltd., a wholly owned subsidiary of Hitachi Ltd. (TSE: 6501, "Hitachi") has announced that in association with The Guardian, it will be hosting a seminar on Social Innovation and the Future of Healthcare.

The number of people in the UK over 65 years old is growing rapidly. Coupled with a predicted upswing in obesity-related illnesses and other 'lifestyle' conditions, this presents significant new challenges for a healthcare sector already under pressure.

At the same time, advances in 'smart' healthcare systems - informatics, biometrics and other smart technologies - promise to dramatically reconceive the delivery of healthcare in the UK. Prevention, over treatment, seems poised to dominate healthcare in the future. While these technologies will empower patients to take a more central role in their care, they also bring up questions about the implications of smart healthcare systems upon ethical issues, the role of the medical profession and of healthcare facilities themselves.

The seminar, entitled 'How can technology and Social Innovation shape the healthcare system for the future?' will discuss the impacts of technological advances in the healthcare sector within the UK, risks and benefits including ethical issues around big data, the potential to adapt to the changing nature of disease and the changing roles of patients, professionals and infrastructure.

Key experts speaking at the event include: Jo Confino, executive editor of the Guardian, Adrian Conduit, Hitachi Consulting UK Healthcare Practice director of business development, Eva Reichl, Hitachi Data Systems EMEA director healthcare and life sciences, Alan Payne, Bupa digital director, and Katherine Rake, chief executive, Healthwatch.

Healthcare forms a key pillar of the global rollout of Hitachi's Social Innovation
Business, providing market-leading infrastructure solutions underpinned by highly reliable and highly efficient IT technology, as part of its 2015 Mid-term Management Plan. In the UK, Hitachi established the European Big Data Research Laboratory, with a focus on health care in June 2013 and has started Proof of Concept projects for the use of informatics to improve healthcare with the National Health Service (NHS) England (Greater Manchester).

This is the third seminar Hitachi has hosted in conjunction with The Guardian. The event will take place from 6.00am-9.15pm on Wednesday 26 November 2014 at The Guardian, King’s Place, York Way, London, N1 9GU.

For further information, please visit:
http://www.theguardian.com/sustainable-business/2014/oct/29/technology-social-innovation-shape-future-healthcare-system-free-event

About Hitachi Europe Ltd.
Hitachi Europe Ltd., a subsidiary of Hitachi, Ltd., is headquartered in Maidenhead, UK. The company is focused on its Social Innovation Business - delivering innovations that answer society's challenges. Hitachi Europe and its subsidiary companies offers a broad range of information & telecommunication systems; rail systems, power and industrial systems; industrial components & equipment; automotive systems, financial services; digital media & consumer products and others with operations and research & development Laboratories across EMEA.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...